Xeljanz (tofacitinib) can affect patients with liver issues. The medication has the potential to cause liver damage by altering enzyme levels, as shown in clinical trials. For patients with pre-existing liver conditions, close monitoring during Xeljanz treatment is essential. Symptoms of liver damage may include stomach pain, yellowing of the eyes or skin, and dark urine.
If you experience any of these symptoms, it’s important to inform your doctor. Liver function tests should be done before and during Xeljanz treatment to monitor liver function. It’s crucial to discuss the potential risks and benefits of Xeljanz treatment with your healthcare provider, especially if you have underlying liver issues.
